Literature DB >> 8471408

The reproducibility of quinine bioavailability.

G Paintaud1, G Alván, O Ericsson.   

Abstract

Plasma concentrations of quinine were measured in six healthy volunteers after a duplicate administration of 15 mg kg-1 of quinine hydrochloride orally and the administration of 15 mg kg-1 of quinine dihydrochloride as an infusion over 6 h. Quinine absorption rate devised by deconvolution was shown to be complete in less than 2 h. The mean (+/- s.d.) fraction available (F) was 0.76 (0.11) after both oral doses and maximum plasma drug concentrations occurred at 1.90 (0.83) h and 2.00 (0.30) h, respectively. The reproducibility of absorption was high, with a within-subject coefficient of variation of less than 10% for Cmax, AUC and F. Thus, quinine absorption is extensive, fast and reproducible in healthy volunteers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8471408      PMCID: PMC1381580          DOI: 10.1111/j.1365-2125.1993.tb05698.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. III. THE PHYSIOLOGICAL DISPOSITION AND ANTIMALARIAL ACTIVITY OF THE CINCHONA ALKALOIDS.

Authors:  J V Taggart; D P Earle; R W Berliner; C G Zubrod; W J Welch; N B Wise; E F Schroeder; I M London; J A Shannon
Journal:  J Clin Invest       Date:  1948-05       Impact factor: 14.808

2.  Single-dose comparative kinetics and bioavailability study of quinine hydrochloride, quinidine sulfate and quinidine bisulfate sustained-release in healthy male volunteers.

Authors:  A Jamaludin; M Mohamed; V Navaratnam; N Mohamed; E Yeoh; W Wernsdorfer
Journal:  Acta Leiden       Date:  1988

3.  Estimation of drug absorption rates using a deconvolution method with nonequal sampling times.

Authors:  K Iga; Y Ogawa; T Yashiki; T Shimamoto
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

4.  Human plasma and urine quinine levels following tablets, capsules, and intravenous infusion.

Authors:  A P Hall; A W Czerwinski; E C Madonia; K L Evensen
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

5.  Disposition of oral quinine in acute falciparum malaria.

Authors:  W Supanaranond; T M Davis; S Pukrittayakamee; K Silamut; J Karbwang; P Molunto; L Chanond; N J White
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  The bioavailability of quinine.

Authors:  J C Garnham; K Raymond; E Shotton; P Turner
Journal:  J Trop Med Hyg       Date:  1976-12

7.  Relative bioavailability of the hydrochloride, sulphate and ethyl carbonate salts of quinine.

Authors:  A Jamaludin; M Mohamad; V Navaratnam; K Selliah; S C Tan; W H Wernsdorfer; K H Yuen
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

8.  Lack of effect of oral contraceptive use on the pharmacokinetics of quinine.

Authors:  S Wanwimolruk; S Kaewvichit; O Tanthayaphinant; C Suwannarach; A Oranratnachai
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

9.  Disposition of quinine in plasma, red blood cells and saliva after oral and intravenous administration to healthy adult Africans.

Authors:  L A Salako; A Sowunmi
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

10.  Intra- and inter-individual variation in pharmacokinetics of intravenously infused amoxycillin and ampicillin to elderly volunteers.

Authors:  J Sjövall; G Alván; B Huitfeldt
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

View more
  10 in total

1.  Regional differences in quinine absorption from the undisturbed human colon assessed using a timed release delivery system.

Authors:  J M Hebden; C G Wilson; R C Spiller; P J Gilchrist; E Blackshaw; M E Frier; A C Perkins
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

2.  Pharmacokinetic interactions between ritonavir and quinine in healthy volunteers following concurrent administration.

Authors:  Julius O Soyinka; Cyprian O Onyeji; Sharon I Omoruyi; Adegbenga R Owolabi; Pullela V Sarma; James M Cook
Journal:  Br J Clin Pharmacol       Date:  2010-03       Impact factor: 4.335

Review 3.  Pharmacokinetic interactions of antimalarial agents.

Authors:  P T Giao; P J de Vries
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

4.  Quinine as a potential tracer for medication adherence: A pharmacokinetic and pharmacodynamic assessment of quinine alone and in combination with oxycodone in humans.

Authors:  Shanna Babalonis; Aidan J Hampson; Michelle R Lofwall; Paul A Nuzzo; Sharon L Walsh
Journal:  J Clin Pharmacol       Date:  2015-07-29       Impact factor: 3.126

Review 5.  Nanomedicines for Malaria Chemotherapy: Encapsulation vs. Polymer Therapeutics.

Authors:  Sindisiwe Mvango; William M R Matshe; Abideen O Balogun; Lynne A Pilcher; Mohammed O Balogun
Journal:  Pharm Res       Date:  2018-10-15       Impact factor: 4.200

Review 6.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

7.  Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.

Authors:  S M D K Ganga Senarathna; Kevin T Batty
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

8.  Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man.

Authors:  Rajaa A Mirghani; Orjan Ericsson; Gunnel Tybring; Lars L Gustafsson; Leif Bertilsson
Journal:  Eur J Clin Pharmacol       Date:  2003-03-11       Impact factor: 2.953

9.  Metabolism and elimination of quinine in healthy volunteers.

Authors:  Rajaa A Mirghani; Urban Hellgren; Leif Bertilsson; Lars L Gustafsson; Orjan Ericsson
Journal:  Eur J Clin Pharmacol       Date:  2003-08-12       Impact factor: 2.953

10.  Pharmacokinetic Parameters of Quinine in Healthy Subjects and in Patients with Uncomplicated Malaria in Nigeria: Analysis of Data using a Population Approach.

Authors:  Ayorinde Adehin; Sharon I Igbinoba; Julius O Soyinka; Cyprian O Onyeji; Chinedum P Babalola; Oluseye O Bolaji
Journal:  Curr Ther Res Clin Exp       Date:  2019-09-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.